Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality
Open Access
- 19 July 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 31 (1) , 21-27
Abstract
Objective: To compare interval cancer proportions (ICP) in the faecal immunochemical test (FIT)-based Scottish Bowel Screening Programme (SBoSP) with the former guaiac faecal occult blood test (gFOBT)-based SBoSP and investigate associations between interval cancer (IC) and faecal haemoglobin concentration (f-Hb) threshold, sex, age, deprivation, site, and stage. Methods: The ICP data from first year of the FIT-based SBoSP and the penultimate year of the gFOBT-based SBoSP were compared in a prospective cohort design. Results: With FIT, 801 colorectal cancers (CRCs) were screen detected (SDC), 802 were in non-participants, 548 were ICs, 39 were colonoscopy missed and 72 were diagnosed after incomplete screening; with gFOBT: 540, 904, 556, 45, and 13, respectively. FIT had a significantly higher proportion of SDC compared to IC than gFOBT. For FIT and gFOBT, ICP was significantly higher in women than men. As f-Hb threshold increased, ICP increased and, for any f-Hb threshold for men, a lower threshold was required for comparable ICP in women. In Scotland, the current threshold of ≥80 µg Hb/g faeces would have to be lowered to ≥40 µg Hb/g faeces for women to achieve sex equality for ICP. In the FIT-based SBoSP, there were four times as many stage I SDC than IC. This was reversed in advanced stages, with twice as many stage IV CRC diagnosed as IC versus SDC. Conclusions: Reducing the numbers of IC requires lowering the f-Hb threshold. Using different f-Hb thresholds for women and men could eliminate the sex disparity, but with additional colonoscopy.Keywords
This publication has 25 references indexed in Scilit:
- Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limitedJournal of Medical Screening, 2016
- Colorectal cancer screening: a global overview of existing programmesGut, 2015
- Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclatureGut, 2014
- Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screeningClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Clinical outcomes using a faecal immunochemical test for haemoglobin as a first‐line test in a national programme constrained by colonoscopy capacityUnited European Gastroenterology Journal, 2013
- Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancerClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour siteGut, 2011
- Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancerGut, 2008
- Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational studyThe Lancet Oncology, 2006
- Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992Public Health, 1997